Search Results - "WILAND, Anne M"

Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier by Ensor, Christopher R., Goehring, Kimberly C., Iasella, Carlo J., Moore, Cody A., Lendermon, Elizabeth A., McDyer, John F., Morrell, Matthew R., Sciortino, Christopher M., Venkataramanan, Raman, Wiland, Anne M.

“…Current immunosuppressive regimens with calcineurin inhibitors have improved the management of patients after transplantation. However, their adverse effects…”
Get full text

Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation : A retrospective study by PHILOSOPHE, Benjamin, FARNEY, Alan C, SCHWEITZER, Eugene J, COLONNA, John O, JARRELL, Bruce E, KRISHNAMURTHI, Venkatesh, WILAND, Anne M, BARTLETT, Stephen T

“…To compare portal and systemic venous drainage of pancreas transplants and demonstrate an immunologic and survival superiority of portal venous drainage…”
Get full text

Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy by Vessal, Ghazal, Wiland, Anne M., Philosophe, Benjamin, Fink, Jeffrey C., Weir, Matthew R., Klassen, David K.

“…:  Although steroid withdrawal in simultaneous kidney pancreas transplantation has been shown to be feasible, the results of early steroid withdrawal in…”
Get full text

Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial by WILAND, Anne M, FINK, Jeffrey C, WEIR, Matthew R, PHILOSOPHE, Benjamin, BLAHUT, Steven, WEIR, M. Ryan, COPENHAVER, Beth, BARTLETT, Stephen T

“…Living-donor kidney transplant recipients generally do not receive antibody induction. Induction avoidance may not be appropriate, particularly for…”
Get full text

Daclizumab induction in solid organ transplantation by Wiland, Anne M, Philosophe, Benjamin

“…Antibody induction therapy is used in solid organ transplantation to prevent rejection in the early postoperative period. It is especially useful in high-risk…”
Get more information

Comparison of Azathioprine and Mycophenolate Mofetil for the Prevention of Acute Rejection in Recipients of Pancreas Transplantation by Oh, Jung M., Wiland, Anne M., Klassen, David K., Weidle, Paul J., Bartlett, Stephen T.

“…The study was performed to compare the efficacy and side effects of azathioprine (AZA) and mycophenolate mofetil (MMF) in conjunction with cyclosporine or…”
Get full text

In vitro evaluation of high-level, gentamicin-resistant enterococci isolated from bacteremic patients by Wiland, A M, Plaisance, K I, Schwalbe, R S

“…We attempted to characterize the susceptibility of high-level, gentamicin-resistant (HLGR, minimum inhibitory concentration [MIC] > 2000 micrograms/ml)…”
Get more information

Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients by PASSALACQUA, J.-A, WILAND, A. M, FINK, J. C, BARTLETT, S. T, EVANS, D. A, KEAY, S

“…Infection is a frequent postoperative complication in renal transplant recipients. However, little information is available concerning the effect of…”
Get full text

THE INCREASED INCIDENCE OF BK POLYOMA VIRUS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH PROGRAF: Abstract# 1051 by Fink, Jeffrey C., Wiland, Anne M., Rochussen, Jennifer R., Drachenberg, Cinthia B., Papadimitriou, John P.

Get full text

THE EFFECT OF PROGRAF® COMPARED TO NEORAL® ON GLYCEMIC TRENDS AFTER RENAL TRANSPLANTATION: Abstract# 817 Poster Board #-Session: P74-III by Fink, Jeffrey C., Wiland, Anne M., Philosophe, Benjamin, Blahut, Steven A., Rocchusen, Jennifer R., Wali, Ravinder K., Weir, Matthew R.

Get full text

COST EFFECTIVE MEASURES TO ADMINISTER THYMOGLOBULIN® FOR INDUCTION THERAPY IN PANCREAS TRANSPLANT RECIPIENTS: Abstract# 1135 by Wiland, Anne M., Fink, Jeffrey C., Philosophe, Benjamin, Farney, Alan, Schweitzer, Eugene J., Colonna, John O., Weir, Matthew R., Bartlett, Stephen T.

Get full text

EXPERIENCE WITH THYMOGLOBULIN® INDUCTION THERAPY IN PANCREAS TRANSPLANT RECIPIENTS: Abstract# 1136 by Wiland, Anne M., Fink, Jeffrey C., Philosophe, Benjamin, Farney, Alan C., Schweitzer, Eugene J., Colonna, John O., Weir, Matthew R., Bartlett, Stephen T.

Get full text

A PHARMACOECONOMIC ANALYSES OF BASILIXIMAB IN CADAVERIC RENAL TRANSPLANT PATIENTS WITH DELAYED GRAFT FUNCTION: Abstract# 20 by Wiland, Anne M., Fink, Jeffrey C., Philosophe, Benjamin, Farney, Alan C., Schweitzer, Eugene J., Colonna, John O., Weir, Matthew R., Bartlett, Stephen T.

Get full text

LOW KIDNEY REJECTION RATES WITH BASILIXIMAB INDUCTION AND DELAYED INTRODUCTION OF TACROLIMUS FOR PATIENTS WITH DELAYED GRAFT FUNCTION: Abstract# 569 by Philosophe, Benjamin, Fink, Jeffrey C., Wiland, Anne M., Farney, Alan C., Schweitzer, Eugene J., Colonna, John O., Jarrell, Bruce E., Krishnamurthi, Venkatesh, Bartlett, Stephen T.

Get full text